Filing Details
- Accession Number:
- 0001225208-22-009274
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-04 17:01:14
- Reporting Period:
- 2022-08-02
- Accepted Time:
- 2022-08-04 17:01:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1478748 | J Nelda Connors | 300 Boston Scientific Way Marlborough MA 01752-1234 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-08-02 | 16,088 | $41.58 | 4,877 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 45,442 | Indirect | By Trust |
Footnotes
- Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $41.575 to $41.595, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The most recently filed Form 4 reported 15,965 shares directly beneficially owned by the reporting person and 50,442 shares held by the Nelda J. Connors Trust, for which the reporting person is the sole trustee. 4,990 of the shares previously reported as being directly beneficially owned were in fact held indirectly, by the Nelda J. Connors Trust. A subsequent share transfer of 9,990 shares from the Nelda J. Connors Trust to the reporting person to be held directly was initiated to facilitate the sales reported on this Form 4.